HealthPatch
DeviceThe HealthPatch (Vital Connect) is a wireless patch and continuously measures single-lead ECG, heart rate, respiratory rate, stress, skin temperature, body posture and steps
NCT Number: NCT02933307
Rationale: Monitoring patients' vital signs is done to detect clinical deterioration. For this, the MEWS, a scoring list comprising seven vital signs measured by nursing staff, is used. Although the MEWS provides relevant data on patients' health status, the interval measurements may not capture early deterioration of vital signs, especially during the night. As a result, unsafe situations may occur such as periods of low oxygen saturation and cardiac arrhythmias, which are known to complicate postoperative course. Besides, this way of measuring vital signs may be stressful for patients and disturbs patients' sleep. New technology such as ViSi Mobile and HealthPatch allows for remote continuous monitoring of vital signs using wearable devices transmitting relevant data to nurses and clinicians. With this, the investigators think that clinical deterioration may be detected in an early phase and reduce nurse work load and patient distress.
Objective: to investigate the feasibility of wearable devices on the general ward.
Study design: feasibility study.
Study population: adult patients hospitalized on the internal medicine ward and adult postoperative patients on the surgical ward.
Intervention: patients in the intervention groups will be randomized in one of the two groups. Patients in the group 1 will wear ViSi Mobile; patients in group 2 will wear the HealthPatch. Wearable devices will be worn for at least three days. Regular MEWS measurements take place at usual time points.
Main study parameters/endpoints: Evaluation with patient and care givers (primary outcome measure), MEWS calculations, time between alarm (continuous data) and next regular MEWS measurement (nurse), intervention by nurse after alarm, admission to ICU, complications, side effects of devices, STAI scores, and PCS scores will be documented.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Patients will wear one device for at least three days. Devices can be uncomfortable by being heavy or the patches can start itching. More measurements by nurses can take place when indicated, for example after alarms. The participating patients will fill out the STAI on daily basis and the PCS on the last day of hospitalization. Both questionnaires will take a few minutes to complete. Patients could benefit from early detection of clinical deterioration and early corrective interventions or ICU admissions.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The HealthPatch (Vital Connect) is a wireless patch and continuously measures single-lead ECG, heart rate, respiratory rate, stress, skin temperature, body posture and steps
ViSi Mobile (Sotera Wireless) is wireless device that is able to continuously measure all important vital parameters: ECG, heart rate, oxygen saturation, blood pressure, respiratory rate and skin temperature.
Time frame: 2-3 days after informed consent
Interviews of 15-20 minutes with patients after 2-3 days wearing a device or control group
Time frame: 1 year
Interviews with nurses of 15-20 minutes at the end of the study. Estimated amount of 6 nurses
Time frame: 3 times a day, up to three days.
Time frame: during 2-3 days when the patient wears a device
Time frame: during 2-3 days when the patient wears a device
Time frame: during 2-3 days when the patient wears a device
Time frame: during 2-3 days when the patient participates in this study
Time frame: during 2-3 days when the patient participates in this study
Time frame: during 2-3 days when the patient participates in this study
Time frame: during 2-3 days when the patient wears a device
E.g. Itch or redness
Time frame: during 2-3 days when the patient wears a device
Time frame: Once a day during the 2-3 days the patient participantes in this study
Time frame: On day 2 or 3 when patients participates in the study
Time frame: 1 year
Time frame: On day 1 when patients participates in the study
Extraction from EHR
Time frame: On day 1 when patients participates in the study
Extraction from EHR
Time frame: On day 1 when patients participates in the study
Extraction from EHR
Time frame: On day 1 when patients participates in the study
Extraction from EHR
Radboud University Medical Center
Other
Continuous Monitoring of Vital Signs in Hospitalized Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06447662
Adenocarcinoma, Bronchial Neoplasms
Fayetteville, Arkansas, United States
View Trial DetailsNCT05461430
Adenocarcinoma, Adenoma
Oakland, California, United States
View Trial DetailsNCT02750657
Adenocarcinoma, Carcinoma
Kingston, Ontario, Canada
View Trial DetailsNCT02310230
Adenocarcinoma, Barrett Esophagus
Burlington, Vermont, United States
View Trial Details